SARON: Stereotactic Ablative Radiotherapy for Oligometastatic Non-small cell lung cancer (NSCLC). A UK randomised phase III trial

被引：0
|
作者：
Landau, D. B. [1 ]
Hughes, L. [2 ,3 ]
Ngai, Y. [2 ,3 ]
Hanna, G. G. [4 ]
Conibear, J. [5 ]
Farrelly, L. [2 ,3 ]
Counsell, N. [2 ,3 ]
机构：
[1] Guys & St Thomas NHS Fdn Trust, Oncol, EH, London, England
[2] CRUK, London, England
[3] UCL Canc Trials Ctr, Inst Canc, TJ, London, England
[4] Queens Univ Belfast, Ctr Canc Res & Cell Biol, AE, Belfast, Antrim, North Ireland
[5] St Bartholomews Hosp, Barts Canc Inst, BE, London, England
来源：
LUNG CANCER | 2017年 / 103卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
119
引用
收藏
页码：S54 / S54
页数：1
相关论文
共 50 条
  • [31] The Role of Stereotactic Ablative Radiotherapy for Early-Stage and Oligometastatic Non-small Cell Lung Cancer: Evidence for Changing Paradigms
    Dahele, Max
    Senan, Suresh
    CANCER RESEARCH AND TREATMENT, 2011, 43 (02): : 75 - 82
  • [32] Non-small Cell Lung Cancer Stereotactic ablative Radiotherapy vs. Lobectomy
    Lorenz, Judith
    ZENTRALBLATT FUR CHIRURGIE, 2016, 141 (03): : 237 - 237
  • [33] Stereotactic radiotherapy (SRT) in combination with aumolertinib to treat intracranial oligometastatic non-small cell lung cancer (NSCLC): A phase II, prospective study
    Chen, J. Y.
    Zhang, H.
    Wang, B. Y.
    Wen, J. M.
    Xu, X. Y.
    Li, H. T.
    Fan, M.
    ANNALS OF ONCOLOGY, 2022, 33 : S1588 - S1588
  • [34] Sequential versus standard chemotherapy in advanced non-small cell lung cancer (NSCLC): A phase III randomised trial
    Paesmans, M.
    Berghmans, T.
    Lafitte, J. J.
    Lecomte, J.
    Alexopoulos, C. G.
    Van Cutsem, O.
    Giner, V.
    Efremidis, A.
    Scherpereel, A.
    Sculier, J. P.
    LUNG CANCER, 2006, 52 : S26 - S27
  • [35] A phase III randomised trial comparing sequential to standard chemotherapy in advanced non-small cell lung cancer (NSCLC).
    Sculier, J.
    Lafitte, J.
    Lecomte, J.
    Alexopoulos, C.
    Van Cutsem, O.
    Giner, V.
    Efremidis, A.
    Scherpereel, A.
    Paesmans, M.
    Berghmans, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 367S - 367S
  • [36] Stereotactic ablative radiotherapy (SABR) in medically inoperable early stage non-small cell lung cancer (NSCLC): A single tertiary UK centre experience
    Yip, C.
    Landau, D. B.
    Thomas, C.
    Ahmad, S.
    LUNG CANCER, 2013, 79 : S58 - S58
  • [37] Stereotactic body radiotherapy improves the survival of patients with oligometastatic non-small cell lung cancer
    Ouyang, Wen
    Yu, Jing
    Nuerjiang, Shuake
    Li, Zhijun
    Wang, Dajiang
    Wang, Xiaoyong
    Zhang, Junhong
    Xie, Conghua
    CANCER MEDICINE, 2019, 8 (10): : 4605 - 4614
  • [38] Radiotherapy for oligometastatic tumor improved the prognosis of patients with non-small cell lung cancer (NSCLC)
    Gong, Hong-yun
    Wang, Yi
    Han, Guang
    Song, Qi-bin
    THORACIC CANCER, 2019, 10 (05) : 1136 - 1140
  • [39] Definitive thoracic radiotherapy in oligometastatic stage IV non-small cell lung cancer (NSCLC).
    Fernandes, Annemarie Therese
    Xanthopoulos, Eric
    Handorf, Elizabeth
    Grover, Surbhi
    Sharma, Sonam
    Eaby-Sandy, Beth
    Evans, Tracey L.
    Stevenson, James
    Langer, Corey J.
    Mitra, Nandita
    Apisarnthanarax, Smith
    Lin, Lilie
    Rengan, Ramesh
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [40] Radiotherapy for oligometastatic non-small cell lung cancer patients
    Levy, A.
    Roux, C.
    Mercier, O.
    Issard, J.
    Botticella, A.
    Barlesi, F.
    Le Pechoux, C.
    CANCER RADIOTHERAPIE, 2021, 25 (6-7): : 517 - 522
12345